PIWIL4 Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-68631
Key Product Details
Species Reactivity
Validated:
Human
Applications
Immunocytochemistry/ Immunofluorescence
Label
Unconjugated
Antibody Source
Polyclonal Rabbit IgG
Concentration
Concentrations vary lot to lot. See vial label for concentration. If unlisted please contact technical services.
Product Summary for PIWIL4 Antibody
Immunogen
This antibody was developed against a recombinant protein corresponding to amino acids: GRARVKARGIARSPSATEVGRIQASPLPRSVDLSNNEASSSNGFLGTSRISTNDKYGISSGDAGSTFMERGVKNKQDFMDLSICTREKLAHVRNCKTGS
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Scientific Data Images for PIWIL4 Antibody
Immunocytochemistry/ Immunofluorescence: PIWIL4 Antibody [NBP2-68631]
Immunocytochemistry/Immunofluorescence: PIWIL4 Antibody [NBP2-68631] - Staining of human cell line U-2 OS shows localization to nucleus & mitochondria.Applications for PIWIL4 Antibody
Application
Recommended Usage
Immunocytochemistry/ Immunofluorescence
0.25-2 ug/ml
Application Notes
Recommended conditions:
Fixation/Permeabilization: PFA/Triton X-100
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A purified
Formulation
PBS (pH 7.2) and 40% Glycerol
Preservative
0.02% Sodium Azide
Concentration
Concentrations vary lot to lot. See vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: PIWIL4
Alternate Names
HIWI2, MIWI2
Gene Symbol
PIWIL4
Additional PIWIL4 Products
Product Documents for PIWIL4 Antibody
Product Specific Notices for PIWIL4 Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...